![]() |
Volumn 6, Issue 2, 2009, Pages 137-145
|
Humanitarian Use Device and Humanitarian Device Exemption regulatory programs: Pros and cons
|
Author keywords
Humanitarian Device Exemption; Humanitarian Use Device; Medical device; Pediatric medical device; Product development; Regulatory system; Safety and Improvement Act of 2007
|
Indexed keywords
ADVISORY COMMITTEE;
ARTICLE;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG MANUFACTURE;
FEE;
FOOD AND DRUG ADMINISTRATION;
HUMANITARIAN DEVICE EXEMPTION;
HUMANITARIAN USE DEVICE;
LAW;
MARKETING;
MEDICAL DECISION MAKING;
MEDICAL INFORMATION;
MEDICAL INSTRUMENTATION;
POSTMARKETING SURVEILLANCE;
PRODUCT DEVELOPMENT;
PROFIT;
REIMBURSEMENT;
SAFETY;
STANDARDIZATION;
APPARATUS, EQUIPMENT AND SUPPLIES;
DECISION MAKING;
FINANCIAL MANAGEMENT;
GOVERNMENT REGULATION;
HUMAN;
UNITED STATES;
DECISION MAKING;
DEVICE APPROVAL;
EQUIPMENT AND SUPPLIES;
GOVERNMENT REGULATION;
HUMANS;
MARKETING OF HEALTH SERVICES;
ORPHAN DRUG PRODUCTION;
UNITED STATES;
|
EID: 67449086858
PISSN: 17434440
EISSN: 17452422
Source Type: Journal
DOI: 10.1586/17434440.6.2.137 Document Type: Article |
Times cited : (12)
|
References (14)
|